Skip to main content
Research:
Research
20 Jan 2021

Tackling digital transformation

How biopharma companies can realize the power of digital and prepare for a new reality

Digital technologies, which are driving massive transformation in health care, can help biopharma companies innovate to develop products and services, engage better with consumers, and execute operations more effectively.
Tackling digital transformation: How biopharma companies can realize the power of digital and prepare for a new reality
5 MB PDF

The explosion of digital diagnostics and therapeutics, increasing patient-centeredness, the push for interoperable data, and increased regulatory collaboration are all signs of the tremendous changes that digital technologies are driving in the health care industry.

How can biopharma prepare for this new reality? How should biopharma companies transform their operating and business models to compete? In the report "Tackling digital transformation", we explore five key competencies that can be requisites to enabling digital transformation.

It includes:

  • Driving scientific breakthroughs through data and data partnerships
  • Applying the principles of behavioral science to improve patient outcomes
  • Establishing an enterprise architecture structure
  • Developing predictive analytics and AI capabilities
  • Shifting from “doing digital” to “being digital”

Becoming a digital biopharma company is an ambitious undertaking, and leaders can pursue different paths to get there. 

Did you find this useful?

Yes
No

Thanks for your feedback

If you would like to help improve Deloitte.com further, please complete a 3-minute survey

Get in touch

Luis Fernando Joaquim

Lead partner for Life Sciences & Health Care

Our thinking

Cybersecurity in Life Science & Health Care | Deloitte Brazil

Communicating the value of cybersecurity to boards and leadership.
Research
minute read

Optimizing market access

With public pressure to reduce drug spending, payers are increasingly using formulary tools to help manage market access. This report examines market factors driving market access strategies in different therapeutic areas.
Research
minute read

The right health care the right way

Billions of dollars are wasted annually in the United States on “low value” health care services such as unnecessary diagnostic tests, trips to the emergency room, and avoidable surgeries. Explore how some organizations globally are using innovative approaches and technologies to combat this issue.
Research
minute read

The Future of Health | Deloitte

The life sciences and health care industry is on the brink of large-scale disruption. In a future of health that’s defined by radically interoperable data, open yet secure platforms, and consumer-driven care, what role will you play?
Perspective
3 minute read
Explore our thinking

Let's connect

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited (“DTTL”), its global network of member firms, and their related entities (collectively, the “Deloitte organization”). DTTL (also referred to as “Deloitte Global”) and each of its member firms and related entities are legally separate and independent entities, which cannot obligate or bind each other in respect of third parties. DTTL and each DTTL member firm and related entity is liable only for its own acts and omissions, and not those of each other. DTTL does not provide services to clients. Please see www.deloitte.com/about to learn more.

© 2024. For information, contact Deloitte Global.